Evaluating the implementation of weekly rifapentine-isoniazid (3HP) for tuberculosis prevention among people living with HIV in Uganda: A qualitative evaluation of the 3HP Options Trial.
Musinguzi A, Kasidi JR, Kadota JL, Welishe F, Nakitende A, Akello L, Nakimuli J, Kunihira LT, Opira B, Baik Y, Patel D, Sammann A, Berger CA, Aschmann HE, Nahid P, Belknap R, Kamya MR, Handley MA, Phillips PP, Kiwanuka N, Katamba A, Dowdy DW, Cattamanchi A, Semitala FC, Katahoire AR.
Musinguzi A, et al. Among authors: handley ma.
medRxiv [Preprint]. 2024 Aug 22:2024.08.19.24308041. doi: 10.1101/2024.08.19.24308041.
medRxiv. 2024.
PMID: 39314926
Free PMC article.
Updated.
Preprint.